In a study conducted using colon cancer cell lines, it was discovered that metformin can suppress inflammatory factors’ expression, regulate the inflammatory microenvironment, and limit the progression of CRC by inhibiting the expression of the NLRP3 inflammasome [125]. This evidence concerns the gene NLRP3 and malignant colon neoplasm.